Novartis readies for FDA review of $1 billion CAR-T child cancer hope
ZURICH (Reuters) - Two decades ago in a Memphis, Tenn., hospital lab, cancer scientist Dario Campana and his team were hunting for a new way to fight deadly acute lymphoblastic leukemia (ALL).
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
More News: Acute Leukemia | Acute Lymphoblastic Leukemia | Cancer | Cancer & Oncology | Children | Health | Hospitals | Leukemia